New Drug Update 2010-2011 Faculty Disclaimer - CME Conferences
New Drug Update 2010-2011 Faculty Disclaimer - CME Conferences
New Drug Update 2010-2011 Faculty Disclaimer - CME Conferences
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2 nd Annual Essentials in Primary Care<br />
Fall Conference<br />
Friday, November 11, <strong>2011</strong><br />
Azilsartan medoxomil - Edarbi<br />
First ARB in combination with chlorthalidone pending<br />
FDA approval<br />
Change in systolic blood pressure:<br />
End point<br />
Clinic SBP<br />
(change from baseline, mm<br />
Hg)<br />
Change in 24-h mean SBP<br />
(change from baseline, mm<br />
Hg)<br />
Azilsartan<br />
Chlorthalidon<br />
e<br />
40/25 (n=355)<br />
Azilsartan<br />
Chlorthalidone<br />
80/25 (n=352)<br />
Olmesartan<br />
HCTZ<br />
40/25 (n=364)<br />
- 42.5 - 44.0 - 37.1
Change language